Bone Changes in OA

*Osteoarthritis Biomarkers and Treatments*

[60] Roelants M, Delecluse C,

conventional physiotherapy in patients with gonarthrosis: A protocol for a randomized, controlled study. BMC Musculoskeletal Disorders. 2010;**11**:128. Available from: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2903508/

Verschueren S. Whole-body-vibration training increases knee-extension strength and speed of movement in older women. Journal of the American Geriatrics Society. 2004;**52**:901-908

[61] Rehn B, Lidström J, Skoglund J, Lindström B. Effects on leg muscular performance from whole-body

[62] Trans T, Aaboe J, Henriksen M, Christensen R, Bliddal H, Lund H. Effect of whole body vibration exercise on muscle strength and proprioception in females with knee osteoarthritis. The Knee. 2009;**16**(4):256-261. Available from: http://www.sciencedirect.com/science/

article/pii/S0968016008002238

[63] Bokaeian HR, Bakhtiary AH, Mirmohammadkhani M, Moghimi J. The effect of adding whole body vibration training to strengthening training in the treatment of knee osteoarthritis: A randomized clinical trial. Journal of Bodywork and Movement Therapies. 2016;**20**(2):334- 340. Available from: http://www. sciencedirect.com/science/article/pii/

[64] Waller B, Munukka M, Rantalainen T, Lammentausta E, Nieminen MT, Kiviranta I, et al. Effects of high intensity resistance aquatic training on body composition and walking speed in women with mild knee osteoarthritis: A 4-month RCT with 12-month

follow-up. Osteoarthritis and Cartilage. 2017;**25**(8):1238-1246. Available from: http://www.sciencedirect.com/science/

article/pii/S1063458417308695

S1360859215002156

vibration exercise: A systematic review. Scandinavian Journal of Medicine & Science in Sports. 2007;**17**:2-11

**86**

**89**

**Chapter 6**

**Abstract**

narrowing, osteophytes, pain

**1. Introduction**

systems worldwide [1].

Evaluating the Relation between

Synovitis with Pain and Structural

Osteoarthritis (OA) is the most prevalent arthritis worldwide and is a condition affecting the whole joint. Changes in subchondral bone, cartilage integrity and synovitis are recognised during OA progression. Although advances have been made in our understanding of OA pathophysiology, there are no current treatments that delay or halt the progression of the disease. Treatments are largely based upon physical therapies to improve function, anti-inflammatory agents for pain symptoms and joint replacement surgery for late stage disease in large weight bearing joints. There is an urgent need to better understand the pathophysiology of OA that could translate into improved treatments for this condition. In recent years, more advanced imaging techniques including magnetic resonance imaging (MRI) have led to an improved understanding of changes at the bone-cartilage interface in OA, with recognition that loss of integrity at the cartilage-bone junction and development of bone marrow lesions (BMLs) in the subchondral bone are associated with OA pain in large epidemiological studies. In this book chapter, we review the evidence for the role of BMLs and synovitis, particularly in the pathophysiology of hand OA. Based on a systematic review of the literature, we have identified 15 articles reported on

BMLs and synovitis in hand OA, which will be discussed in this chapter.

**Keywords:** hand osteoarthritis, bone marrow lesions, synovitis, joint space

Osteoarthritis (OA) is the most common debilitating arthritis worldwide, with a preponderance for affecting the knee, hip, hand, spine and feet. It is a leading cause of physical disability and pain in our ageing populations worldwide. The rising epidemic of obesity is also contributing to the increasing incidence of OA, with a greater impact on the quality of life of sufferers and healthcare costs in many

In large epidemiological cohorts of OA, hand OA (HOA) in particular causes a significant disease burden. The Framingham Study reported hand OA to have a prevalence of 27.2% [2]. The same study reported that women were more likely to develop hand OA symptoms in comparison to men [3]. In a large European study of

Damage in Hand Osteoarthritis

Bone Marrow Lesions and

*Nidhi Sofat and Soraya Koushesh*

#### **Chapter 6**

## Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural Damage in Hand Osteoarthritis

*Nidhi Sofat and Soraya Koushesh*

### **Abstract**

Osteoarthritis (OA) is the most prevalent arthritis worldwide and is a condition affecting the whole joint. Changes in subchondral bone, cartilage integrity and synovitis are recognised during OA progression. Although advances have been made in our understanding of OA pathophysiology, there are no current treatments that delay or halt the progression of the disease. Treatments are largely based upon physical therapies to improve function, anti-inflammatory agents for pain symptoms and joint replacement surgery for late stage disease in large weight bearing joints. There is an urgent need to better understand the pathophysiology of OA that could translate into improved treatments for this condition. In recent years, more advanced imaging techniques including magnetic resonance imaging (MRI) have led to an improved understanding of changes at the bone-cartilage interface in OA, with recognition that loss of integrity at the cartilage-bone junction and development of bone marrow lesions (BMLs) in the subchondral bone are associated with OA pain in large epidemiological studies. In this book chapter, we review the evidence for the role of BMLs and synovitis, particularly in the pathophysiology of hand OA. Based on a systematic review of the literature, we have identified 15 articles reported on BMLs and synovitis in hand OA, which will be discussed in this chapter.

**Keywords:** hand osteoarthritis, bone marrow lesions, synovitis, joint space narrowing, osteophytes, pain

#### **1. Introduction**

Osteoarthritis (OA) is the most common debilitating arthritis worldwide, with a preponderance for affecting the knee, hip, hand, spine and feet. It is a leading cause of physical disability and pain in our ageing populations worldwide. The rising epidemic of obesity is also contributing to the increasing incidence of OA, with a greater impact on the quality of life of sufferers and healthcare costs in many systems worldwide [1].

In large epidemiological cohorts of OA, hand OA (HOA) in particular causes a significant disease burden. The Framingham Study reported hand OA to have a prevalence of 27.2% [2]. The same study reported that women were more likely to develop hand OA symptoms in comparison to men [3]. In a large European study of 7983 people, 25% of participants with hand pain showed significant hand disability, with 24.2% of subjects reporting OA of any joint and 28.3% subjects having a manual occupation [4]. Such studies demonstrate the significant symptom burden and functional impairment that hand OA places in human populations worldwide.

Pain and loss of function in OA are as a result of pathological changes in the entire joint structure. Specifically in hand OA, structural changes leading to pain and functional impairment include cartilage damage, subchondral bone sclerosis, subchondral cysts, synovitis, osteophyte formation, erosions and bone marrow lesions (BML) [5]. In the clinic, underlying joint damage can be observed clinically as joint deviation and deformity, swelling e.g. formation of distal interphalangeal (DIP) and proximal interphalangeal (PIP) joint swelling and loss of function [5]. In addition to DIP and PIP joint involvement in hand OA, the thumb first carpometacarpal (CMC) joint can also be involved, which functionally can cause severe functional impairment (**Figure 1**). Although mechanical factors with manual occupations are a major risk factor for hand OA, other factors including increasing age and obesity contribute significantly to disease burden [6].

Current therapies for hand OA include improving physical function and strengthening exercises [7], supportive aids including taping devices [8] and pain management [9]. Pain relieving agents currently include topical or oral therapies such as non-steroidal anti-inflammatory drugs (NSAIDs), opioid analgesics and capsaicin [10]. Intra-articular therapies include corticosteroids and hyaluronic acid in suitable cases [11]. Since there are currently no proven disease-modifying therapies for hand OA, there is a huge unmet need to better understand disease pathophysiology, which could lead to the development of improved therapies for hand OA.

Imaging studies in recent years have provided useful insights into the pathophysiology and progression of hand OA [12]. Historically, imaging of the hand in OA has favoured plain radiography (**Figure 1**), but more recently US and MRI have been used in clinical studies to evaluate radiographic changes in HOA. Modalities of imaging used have included plain radiography and magnetic resonance imaging (MRI). Plain radiography is consistently able to identify a number of structural

**Figure 1.**

*Plain radiographic changes in hand osteoarthritis due to thumb first carpometacarpal joint involvement (A) and proximal and distal interphalangeal joint involvement (B).*

**91**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

changes such as joint space narrowing and osteophyte formation [13]. However, other joint tissue structures including synovitis and subchondral bone marrow lesions, which are linked to pain, may not be easily visualised by plain radiography. Numerous cross-sectional studies have proposed radiographic features to be strongly associated with pain and functional impairment [14] which may be better visualised by MRI evaluation for hand OA [15]. MRI has now become widely accepted as a reliable imaging modality for identifying bone marrow lesions (BML) (see **Figure 2**) and synovitis in OA [16], with a large number of studies already conducted in knee OA [17]. With respect to the hand, fewer clinical and imaging correlative studies have been conducted. Studies conducted in the Oslo hand OA cohort has shown MRI features, including BML and synovitis, to be strongly associated with

*Correlation of plain radiographic changes with MRI bone marrow oedema. (A) Wrist joint showing early joint space narrowing and sclerotic changes. (B) Bone marrow oedema in carpal bone on corresponding MRI scan of* 

joint tenderness, making these potential targets for future treatments [18, 19].

Although several studies have now been published with respect to radiographic changes including BMLs, cartilage damage and synovitis associated with structural progression and pain in knee OA in particular, there is no systematic review reporting hand structural changes including MRI, synovitis and cartilage damage in hand OA. In this chapter we sought to summarise existing knowledge on studies evaluating BML, cartilage damage and synovitis in hand OA specifically, since these structural changes are associated with pain in hand OA. We aimed to investigate the most frequent imaging modalities reported in the published literature, which

A systematic literature search was conducted through the following electronic databases: Pubmed (from 1996), EMBASE via Ovid (from 1996), Medline via Ovid (from 1996) and Web of Science via Ovid (from 1970) to June 2018. The inclusion criteria for keyword searches were: bone marrow lesion(s) (BMLs), osteoarthritis (OA), imaging, synovitis, and pain. We included studies that observed the associations between BMLs, synovitis, osteophytes and the development of osteoarthritis pathophysiology under magnetic resonance imaging. Initially, it was agreed to conduct a systematic review comprising of all joints affected by osteoarthritis. After careful search, we found that no previous authors had summarised imaging studies on the progression of BMLs and/or synovitis in HOA by systematic review. We agreed to summarise all available literature in HOA relating clinical features to imaging findings to date by systematic review. For exclusion criteria,

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

**Figure 2.**

*the wrist in the same patient (arrow).*

included plain radiography and MRI.

**2. Search strategy for systematic review**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*

**Figure 2.**

*Osteoarthritis Biomarkers and Treatments*

7983 people, 25% of participants with hand pain showed significant hand disability, with 24.2% of subjects reporting OA of any joint and 28.3% subjects having a manual occupation [4]. Such studies demonstrate the significant symptom burden and functional impairment that hand OA places in human populations worldwide. Pain and loss of function in OA are as a result of pathological changes in the entire joint structure. Specifically in hand OA, structural changes leading to pain and functional impairment include cartilage damage, subchondral bone sclerosis, subchondral cysts, synovitis, osteophyte formation, erosions and bone marrow lesions (BML) [5]. In the clinic, underlying joint damage can be observed clinically as joint deviation and deformity, swelling e.g. formation of distal interphalangeal (DIP) and proximal interphalangeal (PIP) joint swelling and loss of function [5]. In addition to DIP and PIP joint involvement in hand OA, the thumb first carpometacarpal (CMC) joint can also be involved, which functionally can cause severe functional impairment (**Figure 1**). Although mechanical factors with manual occupations are a major risk factor for hand OA, other factors including increasing

age and obesity contribute significantly to disease burden [6].

Current therapies for hand OA include improving physical function and strengthening exercises [7], supportive aids including taping devices [8] and pain management [9]. Pain relieving agents currently include topical or oral therapies such as non-steroidal anti-inflammatory drugs (NSAIDs), opioid analgesics and capsaicin [10]. Intra-articular therapies include corticosteroids and hyaluronic acid in suitable cases [11]. Since there are currently no proven disease-modifying therapies for hand OA, there is a huge unmet need to better understand disease pathophysiology, which could lead to the development of improved therapies for hand OA. Imaging studies in recent years have provided useful insights into the pathophysiology and progression of hand OA [12]. Historically, imaging of the hand in OA has favoured plain radiography (**Figure 1**), but more recently US and MRI have been used in clinical studies to evaluate radiographic changes in HOA. Modalities of imaging used have included plain radiography and magnetic resonance imaging (MRI). Plain radiography is consistently able to identify a number of structural

*Plain radiographic changes in hand osteoarthritis due to thumb first carpometacarpal joint involvement (A)* 

*and proximal and distal interphalangeal joint involvement (B).*

**90**

**Figure 1.**

*Correlation of plain radiographic changes with MRI bone marrow oedema. (A) Wrist joint showing early joint space narrowing and sclerotic changes. (B) Bone marrow oedema in carpal bone on corresponding MRI scan of the wrist in the same patient (arrow).*

changes such as joint space narrowing and osteophyte formation [13]. However, other joint tissue structures including synovitis and subchondral bone marrow lesions, which are linked to pain, may not be easily visualised by plain radiography.

Numerous cross-sectional studies have proposed radiographic features to be strongly associated with pain and functional impairment [14] which may be better visualised by MRI evaluation for hand OA [15]. MRI has now become widely accepted as a reliable imaging modality for identifying bone marrow lesions (BML) (see **Figure 2**) and synovitis in OA [16], with a large number of studies already conducted in knee OA [17]. With respect to the hand, fewer clinical and imaging correlative studies have been conducted. Studies conducted in the Oslo hand OA cohort has shown MRI features, including BML and synovitis, to be strongly associated with joint tenderness, making these potential targets for future treatments [18, 19].

Although several studies have now been published with respect to radiographic changes including BMLs, cartilage damage and synovitis associated with structural progression and pain in knee OA in particular, there is no systematic review reporting hand structural changes including MRI, synovitis and cartilage damage in hand OA. In this chapter we sought to summarise existing knowledge on studies evaluating BML, cartilage damage and synovitis in hand OA specifically, since these structural changes are associated with pain in hand OA. We aimed to investigate the most frequent imaging modalities reported in the published literature, which included plain radiography and MRI.

#### **2. Search strategy for systematic review**

A systematic literature search was conducted through the following electronic databases: Pubmed (from 1996), EMBASE via Ovid (from 1996), Medline via Ovid (from 1996) and Web of Science via Ovid (from 1970) to June 2018. The inclusion criteria for keyword searches were: bone marrow lesion(s) (BMLs), osteoarthritis (OA), imaging, synovitis, and pain. We included studies that observed the associations between BMLs, synovitis, osteophytes and the development of osteoarthritis pathophysiology under magnetic resonance imaging. Initially, it was agreed to conduct a systematic review comprising of all joints affected by osteoarthritis. After careful search, we found that no previous authors had summarised imaging studies on the progression of BMLs and/or synovitis in HOA by systematic review. We agreed to summarise all available literature in HOA relating clinical features to imaging findings to date by systematic review. For exclusion criteria,

the search strategy results were screened through the titles by two reviewers NS and SK. Studies were excluded if they were: reviews, letters to the editor, case reports, case series or studies which were not in the English language. All searches were restricted to human subjects. No limits were applied to the sex and age of the subjects. Both reviewers independently screened through the abstracts to exclude any irrelevant articles and eligible full articles were obtained to further analyse the criteria for review. Studies were eligible if they examined BMLs, synovitis and other structural changes using imaging techniques in participants with hand OA. Following the initial search, studies reporting data on hand OA only were included in the systematic review reported herein.

#### **3. Results**

#### **3.1 Data extraction**

The literature flow is depicted by using the Preferred reporting items for Systematic reviews and Meta-Analyses (PRISMA) diagram in **Figure 3**. Following database searches, 2831 articles were extracted for title screening. Following exclusion of duplicate studies and obvious exclusions, 2796 papers were removed and the remaining 35 studies were selected for abstract screening.

Of the 35 studies selected for screening, 19 did not meet the inclusion criteria (bone marrow lesion(s), osteoarthritis, imaging, synovitis, and pain). Full text articles were obtained for 15 studies and independently reviewed by the same two reviewers (NS and SK) for relevance and quality. Following full text review, one study was removed as it was the abstract of a full publication already included for review. A total of 15 studies were included in this systematic review. The data extracted from each study included: country of study, number of participants, structural changes, type of MRI scanner used and pain scores assessed. A summary of the studies and their demographics is shown in **Table 1**. The structural changes described by each study is summarised in **Table 2**.

#### **3.2 Study characteristics**

The mean age for all studies was 64.4 [18–32]. Most studies (n = 13) were performed on both genders, although the majority of the subjects in each study were female. Only two studies [26, 32] had female subjects only and one study did not report the gender of the participants [25]. Of these studies, 13 were from observational cohort studies: the Hand OSTeoarthritis in secondary care (HOSTAS) [27, 29–31] the Oslo hand OA cohort [18–23, 25, 32] and a clinical trial: the digital osteoarthritis in refractory hand OA (DORA) study [28]. All articles examined BMLs and various subchondral features using MRI. The strength of the magnetic field was 1.5 T in four studies [27, 29, 26, 30]. Eight studies used a 1.0 T system [18–23, 25, 32] whereas one study [28] used the 0.2 T system in two patients only. Only one study used a 3.0 T system [24] while one study did not report the MRI system used [31].

#### **3.3 Data from cohort observational studies**

In the HOSTAS study, 87 subjects with primary hand OA were included, of which 82% were women [27]. All participants had radiographic measures and MRI scans conducted, with Kellgren-Lawrence grading (KL) (0–4) and OARSI grading methods [osteophytes 0–3, joint space narrowing (JSN)] for radiographic severity collected. Radiographic progression over the 2-year period was considered as

**93**

**Figure 3.**

*PRISMA flow diagram for systematic review.*

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

an increase in score of ≥1. Associations between MR features and radiographic progression were explored after adjusting for age, sex, body mass index (BMI), synovitis and BML. The group analysed 696 joints in their study, to find that BMLs and synovitis were both associated with radiographic progression by plain radiography and MRI. In comparing plain radiographic versus MRI changes, BMLs grade 2/3 were associated with KL progression, while BML grade 1 was not. Synovitis also

A number of studies have been reported by the Oslo Hand OA cohort, which was initially established in 2001. This cohort underwent extensive evaluation from 2001 to 2003, with further follow-up from 2008 to 2009. A number of observations of pain and functional characteristics in relation to imaging scores have been reported in this cohort. In their first report, Haugen et al. [18] reported the associations between MRI features and measures of pain and physical function in hand OA. Eighty-five participants (77 women) with mean age 68.8 (5.6) years underwent contrast-enhanced MRI of the interphalangeal joints (dominant hand) and clinical joint assessment. One investigator read the MRIs for presence/severity of changes including osteophytes, joint space narrowing, erosions and BMLs. A reliable scoring system previously developed by the authors was used to assess changes [20].

showed graded associations with KL radiographic progression.

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*

**Figure 3.** *PRISMA flow diagram for systematic review.*

an increase in score of ≥1. Associations between MR features and radiographic progression were explored after adjusting for age, sex, body mass index (BMI), synovitis and BML. The group analysed 696 joints in their study, to find that BMLs and synovitis were both associated with radiographic progression by plain radiography and MRI. In comparing plain radiographic versus MRI changes, BMLs grade 2/3 were associated with KL progression, while BML grade 1 was not. Synovitis also showed graded associations with KL radiographic progression.

A number of studies have been reported by the Oslo Hand OA cohort, which was initially established in 2001. This cohort underwent extensive evaluation from 2001 to 2003, with further follow-up from 2008 to 2009. A number of observations of pain and functional characteristics in relation to imaging scores have been reported in this cohort. In their first report, Haugen et al. [18] reported the associations between MRI features and measures of pain and physical function in hand OA. Eighty-five participants (77 women) with mean age 68.8 (5.6) years underwent contrast-enhanced MRI of the interphalangeal joints (dominant hand) and clinical joint assessment. One investigator read the MRIs for presence/severity of changes including osteophytes, joint space narrowing, erosions and BMLs. A reliable scoring system previously developed by the authors was used to assess changes [20].

*Osteoarthritis Biomarkers and Treatments*

**3. Results**

**3.1 Data extraction**

**3.2 Study characteristics**

included in the systematic review reported herein.

remaining 35 studies were selected for abstract screening.

described by each study is summarised in **Table 2**.

**3.3 Data from cohort observational studies**

the search strategy results were screened through the titles by two reviewers NS and SK. Studies were excluded if they were: reviews, letters to the editor, case reports, case series or studies which were not in the English language. All searches were restricted to human subjects. No limits were applied to the sex and age of the subjects. Both reviewers independently screened through the abstracts to exclude any irrelevant articles and eligible full articles were obtained to further analyse the criteria for review. Studies were eligible if they examined BMLs, synovitis and other structural changes using imaging techniques in participants with hand OA. Following the initial search, studies reporting data on hand OA only were

The literature flow is depicted by using the Preferred reporting items for Systematic reviews and Meta-Analyses (PRISMA) diagram in **Figure 3**. Following database searches, 2831 articles were extracted for title screening. Following exclusion of duplicate studies and obvious exclusions, 2796 papers were removed and the

Of the 35 studies selected for screening, 19 did not meet the inclusion criteria (bone marrow lesion(s), osteoarthritis, imaging, synovitis, and pain). Full text articles were obtained for 15 studies and independently reviewed by the same two reviewers (NS and SK) for relevance and quality. Following full text review, one study was removed as it was the abstract of a full publication already included for review. A total of 15 studies were included in this systematic review. The data extracted from each study included: country of study, number of participants, structural changes, type of MRI scanner used and pain scores assessed. A summary of the studies and their demographics is shown in **Table 1**. The structural changes

The mean age for all studies was 64.4 [18–32]. Most studies (n = 13) were performed on both genders, although the majority of the subjects in each study were female. Only two studies [26, 32] had female subjects only and one study did not report the gender of the participants [25]. Of these studies, 13 were from observational cohort studies: the Hand OSTeoarthritis in secondary care (HOSTAS) [27, 29–31] the Oslo hand OA cohort [18–23, 25, 32] and a clinical trial: the digital osteoarthritis in refractory hand OA (DORA) study [28]. All articles examined BMLs and various subchondral features using MRI. The strength of the magnetic field was 1.5 T in four studies [27, 29, 26, 30]. Eight studies used a 1.0 T system [18–23, 25, 32] whereas one study [28] used the 0.2 T system in two patients only. Only one study used a 3.0 T system [24] while one study did not report the MRI system used [31].

In the HOSTAS study, 87 subjects with primary hand OA were included, of which 82% were women [27]. All participants had radiographic measures and MRI scans conducted, with Kellgren-Lawrence grading (KL) (0–4) and OARSI grading methods [osteophytes 0–3, joint space narrowing (JSN)] for radiographic severity collected. Radiographic progression over the 2-year period was considered as

**92**


**95**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

The Netherlands (HOSTAS)

Norway (Oslo HOA)

Haugen et al. [18] BML, synovitis, flexor tenosynovitis, osteophytes, erosions, attrition, malalignment

Haugen et al. [20] BML, synovitis, flexor tenosynovitis, osteophytes, jsn, erosions, malalignment, cysts,

Haugen et al. [21] BML, synovitis, flexor tenosynovitis, osteophytes, JSN, malalignment, cysts, erosion,

Haugen et al. [23] BML, synovitis, flexor tenosynovitis, osteophytes, JSN, malalignment, cysts, erosion,

BML, synovitis, flexor tenosynovitis, osteophytes, JSN, cyst, malalignment, erosion

BML, synovitis, flexor tenosynovitis, osteophytes, joint space narrowing (JSN), cysts

Haugen et al. [25] BML, synovitis, erosion, cysts, osteophytes, cartilage space loss, malalignment

Roux et al. [28] BML, synovitis, flexor tenosynovitis, osteophytes, JSN, cyst, malalignment, erosion

Wolski et al. [32] BML, synovitis, osteophytes, JSN, cyst, malalignment, attrition, erosion, sclerosis

**Country Clinical outcome measures**

> AUSCAN VAS SF-36 HADS

**Imaging modalities measured**

Plain radiograph Kellgren-Lawrence

Kellgren-Lawrence

Scoring MRI system not reported

Scoring 1.0 T MRI

AUSCAN Plain radiograph

A number of questionnaires and clinical examination of the hands were used to assess pain and physical function. Joints were palpated by a rheumatologist to assess the presence of tenderness. To evaluate pain and function in the hands, patients completed self-administered questionnaires including the Australian/Canadian (AUSCAN) hand index, functional index of hand osteoarthritis (FIHOA) and the Arthritis Impact Measurement Scale 2 (AIMS-2). In addition, grip strength was screened for by the use of a hand dynamometer. Linear regression analysis adjusted for age and sex was used to examine the association between MRI abnormalities,

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

524 (86% women) Mean age = 61.9%

21 (100% women) Mean age = 69.9

**Publication Structural changes**

Haugen et al. [19] BML, synovitis

*Publications included in systematic review by clinical outcome and imaging measures.*

collateral ligament

Liu et al. [29] BML, synovitis, flexor tenosynovitis, cyst Kroon et al. [30] BML, synovitis, osteophytes, JSN, effusion

*Structural changes in hand osteoarthritis publications reviewed.*

Kroon et al. [31] BML, synovitis

attrition, collateral ligament

BML, synovitis, osteophytes, JSN, erosion

attrition Haugen et al. [22] BML, synovitis, erosion, central erosion

**Publication Number of participants and mean age**

Kroon et al. [31]

Wolski et al. [32]

Kortekaas et al.

Ramonda et al.

Damman et al.

[24]

[26]

[27]

**Table 2.**

**Table 1.**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*


#### **Table 1.**

*Osteoarthritis Biomarkers and Treatments*

**Publication Number of participants and mean age**

> 85 (91% women) Mean age = 68.8

70 (90% women) Mean age = 67.9

10 (90% women) Mean age = 69.5

106 (92% women) Mean age = 68.9

70 (90% women) Mean age = 67.9

74 (91% women) Mean age = 67.9

20 (95% women) Mean age = 65.8

11 (100% women) Mean age = 59.0

87 (82% women) Mean age = 59.0

18 (77.8% women) Mean age = 64.4

Mean age = 59.4


review) Mean age = 60.1

289 (83% women) total

women) = MRI subjects −87 = Ultrasound subjects (excluded from

Liu et al. [29] 105(83% women)

16 [13 with erosive hand] (62% women) Mean age = 57.0

Haugen et al. [18]

Haugen et al. [19]

Haugen et al. [20]

Haugen et al. [21]

Haugen et al. [22]

Haugen et al. [23]

Kortekaas et al. [24]

Haugen et al. [25]

Ramonda et al. [26]

Damman et al. [27]

Roux et al. [28]

Kroon et al. [30]

**Country Clinical outcome measures**

> AUSCAN FIHOA AIMS-2 Grip strength

> AUSCAN Grip strength

during physical examination

Norway Pain assessed

Italy AUSCAN

VAS Dreiser FIHOA

VAS Dreiser FIHOA

AUSCAN VAS SF-36 MHQ

AUSCAN VAS

Norway (Oslo HOA)

Norway (Oslo HOA)

Norway (Oslo HOA)

Norway (Oslo HOA)

Norway (Oslo HOA)

Norway (Oslo HOA)

Norway (Oslo HOA)

The Netherlands (HOSTAS)

France (DORA)

The Netherlands (HOSTAS)

The Netherlands (HOSTAS) (LUMC)

**Imaging modalities measured**

Plain radiograph Kellgren-Lawrence

Kellgren-Lawrence

Kellgren-Lawrence

Kellgren-Lawrence

Plain radiograph Kellgren-Lawrence

Kellgren-Lawrence

Plain radiograph 3.0 T MRI Ultrasound

Plain radiograph Kellgren-Lawrence

Kellgren-Lawrence

Plain radiograph Kellgren-Lawrence

Plain radiograph Kellgren-Lawrence

Plain radiograph MRI 1.5 T Ultrasound

Scoring 1.0 T MRI

Scoring 1.0 T MRI

Scoring 1.0 T MRI

Scoring 1.0 T MRI

Scoring 1.0 T MRI

Scoring 1.0 T MRI

1.0 T MRI

Scoring 1.5 T MRI

Scoring 1.5 T MRI

Scoring 0.2 T MRI (2 patients)

Scoring 1.5 T MRI

AUSCAN Plain radiograph

Not applicable Plain radiograph

AUSCAN Plain radiograph

AUSCAN Plain radiograph

AUSCAN Plain radiograph

Not applicable Plain radiograph

**94**

*Publications included in systematic review by clinical outcome and imaging measures.*


#### **Table 2.**

*Structural changes in hand osteoarthritis publications reviewed.*

A number of questionnaires and clinical examination of the hands were used to assess pain and physical function. Joints were palpated by a rheumatologist to assess the presence of tenderness. To evaluate pain and function in the hands, patients completed self-administered questionnaires including the Australian/Canadian (AUSCAN) hand index, functional index of hand osteoarthritis (FIHOA) and the Arthritis Impact Measurement Scale 2 (AIMS-2). In addition, grip strength was screened for by the use of a hand dynamometer. Linear regression analysis adjusted for age and sex was used to examine the association between MRI abnormalities,

pain questionnaires and grip strength. Logistic regression was used to further validate linear regression analysis by evaluating associations between MRI features and tenderness of the joints. All features were associated with tenderness of the joints, attrition, osteophytes, synovitis and erosions in the PIP and DIP joints respectively. In the multivariate model, BML and synovitis showed a significant association with joint tenderness (both after adjustment for age, sex and radiographic severity) independently of each other. The MRI summed scores were not significantly associated with AUSCAN pain/physical function and the AIMS-2 hand/finger subscales. Conversely, MRI summed scores for osteophytes and attrition were the only MRIdefined features that were associated with grip strength (B = −0.39; p < 0.001) and FIHOA (B = 0.58; P = 0.005), respectively.

Studies from the same group have aimed to validate scoring systems for MRIassessed changes in the hand [20] and demonstrated that MRI-detected changes, including synovitis, BMLs and joint space narrowing are predictors of radiographic progression in hand OA [22]. More recently, the same group have reported that MRI-defined synovitis and BMLs are related to changes in joint tenderness in a 5-year longitudinal study of the Oslo hand osteoarthritis (OA) cohort [19]. A total of 70 participants (63 women, mean (SD) age 67.9 (5.5) years) were included. The investigators evaluated BMLs and contrast-enhanced synovitis in the distal and proximal interphalangeal joints on 0–3 scales in n = 69 and 48 patients respectively. The goal was to investigate tenderness of each joint and MRI features in a longitudinal manner. With the use of generalised estimated equations (GEE), the same joints that showed no tenderness at baseline visit were assessed during the follow up visit to determine whether incident/increasing BML and synovitis scores were correlated with de novo tenderness [19]. In joints that showed tenderness during baseline visits, the investigators assessed whether decreasing synovitis and BML were positively correlated with the loss of joint tenderness, adjusting for sex, age, BMI, changes in radiographic OA and follow-up time. The investigators found that the same joints in participants which showed no joint tenderness at their baseline visit were associated with joint tenderness upon increasing/incident BML and synovitis. An increase in incident synovitis was detected in 45 out of 220 joints whereas BML were detected in 47 out of 312 joints.

#### **3.4 Correlation of MRI changes with plain radiography**

Several studies have evaluated the reliability of MRI scanning in assessing structural changes in hand OA in relation to clinical symptoms. Korteekas et al. [24] evaluated 16 participants with HOA. The study group had a median age of 57, 62% of the group were women and 13 had erosive OA. In the study, finger joints in the right hand were studied using a 3 Tesla MRI scanner with contrast using gadolinium. Pain was assessed on the same day of MRI examinations and radiographs.

The authors found that detection of synovial thickening for MRI was 43% and for US it was 42%. The most prevalent MRI features were osteophytes, BML and erosions. In contrast to radiographs, MRI scanning was more sensitive at detecting structural changes. A correlation coefficient of 0.43 was found for synovial thickening between US and MRI and it was 0.49 for osteophytes. US was found to be more sensitive for the detection of osteophytes, whereas MRI was more sensitive at detecting synovial thickening. Pain upon palpation was associated with structural changes including synovial thickening, collateral ligaments, BML, erosions and osteophytes.

Other studies have also demonstrated that MRI is a reliable and reproducible method for detecting HOA changes in the interphalangeal joints [23] and thumb base first carpometacarpal joint [30]. Interestingly, in thumb base OA, structural damage was more strongly associated with pain than synovitis [30]. In the HOSTAS

**97**

**4. Discussion**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

study, which was a large study of 92 participants with HOA [29], interphalangeal and thumb base joints were evaluated to demonstrate that MRI-identified BMLs in HOA were associated with pain and also interacted with synovitis. Findings in DIP/ PIP and thumb base HOA have also been replicated in erosive hand OA [26]. With respect to bone texture, roughness in proximal bone texture in finger joints has been shown to be associated with MRI-defined osteophytes in finger joints without

In a clinical trial of hand OA, Chevalier et al. [33] evaluated French participants in the digital osteoarthritis in refractory hand OA (DORA) study. This multi-centre study recruited 99 participants and randomised 85 to placebo or adalimumab anti-TNF therapy. Mean age was 62 years, 855 were women, with the mean level of pain at baseline of 62 mm by the visual analogue scale (VAS) for pain. The primary outcome measure was the percentage of patients with an improvement of more than 505 in global pain (VAS) between baseline and 6 weeks' therapy. At 6 weeks, there was no significant difference in VAS pain outcomes between the adalimumab and the placebo groups [33]. In a smaller sub-study analysis of the DORA study, Roux et al. [28] evaluated the clinical findings and imaging measures from the DORA study. The group reported that of the 18 participants recruited and 144 joints studied, MRI-measured synovitis in the dominant hand was not correlated with radiological scores, clinical or biological markers of inflammation. A strong correlation was reported between other MRI features including joint space narrowing and osteophyte formation. Serum IL-1 was also associated with structural damage and

radiographic OA, which could assist in detecting early HOA changes.

**3.5 Hand OA in the context of inflammatory arthritis**

An important issue in hand arthritis studies is the co-existence of OA and rheumatoid arthritis (RA) in many patients. The factor of co-existing OA and RA in people with hand arthritis has recently been addressed by Loef et al. [34]. The group investigated the effect of TNF inhibitors (TNFi) on incidental and progressive hand OA in subjects with recent-onset RA over a 10 year follow-up. Plain radiographs of 262 subjects with RA (mean age 52 years, 66% women), from the BeSt study had osteophyte scoring conducted. Osteophytes in the DIP/PIP joints were scored using the Osteoarthritis Research Society International atlas (0–3; summed score 0–54) and according to Kellgren-Lawrence (KL) score (0–4; summed score 0–72) at baseline and 10 year follow-up. The use of TNF inhibitor treatment was assessed at 3 monthly visits. The group evaluated associations between TNF inhibitor treatment and HOA using generalised linear regression models and estimating equations. A total of 58% of patients were treated with TNFi with a median duration of 42 months. There were 55% of patients who had hand OA in any IP joint at baseline. For individual patients, TNFi duration did not affect incidental hand OA. However, on a monthly basis, TNFi treatment resulted in a reduced relative risk (RR) of hand OA progression in the DIP joints (relative risk (RR) 0.987 (95% CI 0.978, 0.996) but not in the PIP joints. The study concluded that TNFi treatment was associated with a reduced risk of hand OA progression in DIP joints but not in PIP joints after 10 years. The effect sizes in this study were small and were limited to DIP joint involvement, but suggest that TNF alpha can influence disease course in HOA.

This systematic review has identified studies from the literature which demonstrate that joint space narrowing, osteophytes, synovitis and BMLs are all structural

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

impaired function.

#### *Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*

study, which was a large study of 92 participants with HOA [29], interphalangeal and thumb base joints were evaluated to demonstrate that MRI-identified BMLs in HOA were associated with pain and also interacted with synovitis. Findings in DIP/ PIP and thumb base HOA have also been replicated in erosive hand OA [26]. With respect to bone texture, roughness in proximal bone texture in finger joints has been shown to be associated with MRI-defined osteophytes in finger joints without radiographic OA, which could assist in detecting early HOA changes.

In a clinical trial of hand OA, Chevalier et al. [33] evaluated French participants in the digital osteoarthritis in refractory hand OA (DORA) study. This multi-centre study recruited 99 participants and randomised 85 to placebo or adalimumab anti-TNF therapy. Mean age was 62 years, 855 were women, with the mean level of pain at baseline of 62 mm by the visual analogue scale (VAS) for pain. The primary outcome measure was the percentage of patients with an improvement of more than 505 in global pain (VAS) between baseline and 6 weeks' therapy. At 6 weeks, there was no significant difference in VAS pain outcomes between the adalimumab and the placebo groups [33]. In a smaller sub-study analysis of the DORA study, Roux et al. [28] evaluated the clinical findings and imaging measures from the DORA study. The group reported that of the 18 participants recruited and 144 joints studied, MRI-measured synovitis in the dominant hand was not correlated with radiological scores, clinical or biological markers of inflammation. A strong correlation was reported between other MRI features including joint space narrowing and osteophyte formation. Serum IL-1 was also associated with structural damage and impaired function.

#### **3.5 Hand OA in the context of inflammatory arthritis**

An important issue in hand arthritis studies is the co-existence of OA and rheumatoid arthritis (RA) in many patients. The factor of co-existing OA and RA in people with hand arthritis has recently been addressed by Loef et al. [34]. The group investigated the effect of TNF inhibitors (TNFi) on incidental and progressive hand OA in subjects with recent-onset RA over a 10 year follow-up. Plain radiographs of 262 subjects with RA (mean age 52 years, 66% women), from the BeSt study had osteophyte scoring conducted. Osteophytes in the DIP/PIP joints were scored using the Osteoarthritis Research Society International atlas (0–3; summed score 0–54) and according to Kellgren-Lawrence (KL) score (0–4; summed score 0–72) at baseline and 10 year follow-up. The use of TNF inhibitor treatment was assessed at 3 monthly visits. The group evaluated associations between TNF inhibitor treatment and HOA using generalised linear regression models and estimating equations. A total of 58% of patients were treated with TNFi with a median duration of 42 months. There were 55% of patients who had hand OA in any IP joint at baseline. For individual patients, TNFi duration did not affect incidental hand OA. However, on a monthly basis, TNFi treatment resulted in a reduced relative risk (RR) of hand OA progression in the DIP joints (relative risk (RR) 0.987 (95% CI 0.978, 0.996) but not in the PIP joints. The study concluded that TNFi treatment was associated with a reduced risk of hand OA progression in DIP joints but not in PIP joints after 10 years. The effect sizes in this study were small and were limited to DIP joint involvement, but suggest that TNF alpha can influence disease course in HOA.

#### **4. Discussion**

This systematic review has identified studies from the literature which demonstrate that joint space narrowing, osteophytes, synovitis and BMLs are all structural

*Osteoarthritis Biomarkers and Treatments*

FIHOA (B = 0.58; P = 0.005), respectively.

in 47 out of 312 joints.

**3.4 Correlation of MRI changes with plain radiography**

Several studies have evaluated the reliability of MRI scanning in assessing structural changes in hand OA in relation to clinical symptoms. Korteekas et al. [24] evaluated 16 participants with HOA. The study group had a median age of 57, 62% of the group were women and 13 had erosive OA. In the study, finger joints in the right hand were studied using a 3 Tesla MRI scanner with contrast using gadolinium. Pain was assessed on the same day of MRI examinations and radiographs. The authors found that detection of synovial thickening for MRI was 43% and for US it was 42%. The most prevalent MRI features were osteophytes, BML and erosions. In contrast to radiographs, MRI scanning was more sensitive at detecting structural changes. A correlation coefficient of 0.43 was found for synovial thickening between US and MRI and it was 0.49 for osteophytes. US was found to be more sensitive for the detection of osteophytes, whereas MRI was more sensitive at detecting synovial thickening. Pain upon palpation was associated with structural changes including synovial thickening, collateral ligaments, BML, erosions and osteophytes. Other studies have also demonstrated that MRI is a reliable and reproducible method for detecting HOA changes in the interphalangeal joints [23] and thumb base first carpometacarpal joint [30]. Interestingly, in thumb base OA, structural damage was more strongly associated with pain than synovitis [30]. In the HOSTAS

pain questionnaires and grip strength. Logistic regression was used to further validate linear regression analysis by evaluating associations between MRI features and tenderness of the joints. All features were associated with tenderness of the joints, attrition, osteophytes, synovitis and erosions in the PIP and DIP joints respectively. In the multivariate model, BML and synovitis showed a significant association with joint tenderness (both after adjustment for age, sex and radiographic severity) independently of each other. The MRI summed scores were not significantly associated with AUSCAN pain/physical function and the AIMS-2 hand/finger subscales. Conversely, MRI summed scores for osteophytes and attrition were the only MRIdefined features that were associated with grip strength (B = −0.39; p < 0.001) and

Studies from the same group have aimed to validate scoring systems for MRIassessed changes in the hand [20] and demonstrated that MRI-detected changes, including synovitis, BMLs and joint space narrowing are predictors of radiographic progression in hand OA [22]. More recently, the same group have reported that MRI-defined synovitis and BMLs are related to changes in joint tenderness in a 5-year longitudinal study of the Oslo hand osteoarthritis (OA) cohort [19]. A total of 70 participants (63 women, mean (SD) age 67.9 (5.5) years) were included. The investigators evaluated BMLs and contrast-enhanced synovitis in the distal and proximal interphalangeal joints on 0–3 scales in n = 69 and 48 patients respectively. The goal was to investigate tenderness of each joint and MRI features in a longitudinal manner. With the use of generalised estimated equations (GEE), the same joints that showed no tenderness at baseline visit were assessed during the follow up visit to determine whether incident/increasing BML and synovitis scores were correlated with de novo tenderness [19]. In joints that showed tenderness during baseline visits, the investigators assessed whether decreasing synovitis and BML were positively correlated with the loss of joint tenderness, adjusting for sex, age, BMI, changes in radiographic OA and follow-up time. The investigators found that the same joints in participants which showed no joint tenderness at their baseline visit were associated with joint tenderness upon increasing/incident BML and synovitis. An increase in incident synovitis was detected in 45 out of 220 joints whereas BML were detected

**96**

changes in HOA that are associated with significant symptomatic burden of pain and functional impairment. MRI and US have been shown to be effective imaging modalities that detect more structural changes that plain radiography alone. MRI allows examination of the joint as a whole organ to directly visualise intra-articular structures significant to the progression of OA such as BMLs, synovitis, osteophytes and erosions in relation to radiographic changes and pain. Our systematic review has also found that synovitis and BMLs in HOA which are detectable by MRI and US in particular, are associated with progression in symptoms over time and therefore may represent valid targets for future interventions aimed at modifying these structural changes. Joint space narrowing and osteophyte formation were also identified to have good correlation between plain radiography and MRI/US identified changes. Future novel therapeutics would benefit from correlation with changes in synovitis, BMLs and joint space narrowing in relation to pain and functional outcome for HOA.

Our systematic review has found that a number of different cohorts around the world demonstrate structural changes observed in HOA. However, the majority of the studies were in European populations. Future studies in distinct Ethnic groups around the world would be helpful to compare and contrast data from existing published studies.

Since HOA has a higher prevalence in females, as reflected by the preponderance of women participants in the studies we identified, future studies which report changes in male participants with HOA, with data on occupation, since manual occupations are known to have a higher risk of HOA, are to be welcomed to compare and contrast the changes observed.

Emerging data from the articles we have reviewed suggest that people with HOA could potentially be stratified for imaging-based structural changes e.g. subjects showing inflammatory changes as evidenced by US or MRI-defined synovitis that could be targeted by NSAIDs or intra-articular steroid injections, or a predominant bone-cartilage damage profile, evidenced by the presence of MRI-defined cartilage loss, joint space narrowing and bone oedema that could be targeted using novel therapeutic agents. Imaging modalities such as MRI and/or US that demonstrate additional structural changes not visualised by plain radiography could aid in improved stratification and development of novel therapeutics for HOA in the future.

#### **Author details**

Nidhi Sofat\* and Soraya Koushesh Institute for Infection and Immunity, St George's, University of London, London, UK

\*Address all correspondence to: nsofat@sgul.ac.uk

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**99**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

knee. Arthritis Care & Research.

[9] Zhang W, Doherty M, Leeb B, Alekseeva L, Arden N, Bijlsma J, et al. EULAR evidence based

Diseases. 2007;**66**(3):377-388

from: https://www.nice.org.uk/ guidance/cg177/resourcese [Accessed:

18 May 2017]

2009;**28**(5):529-533

2013;**66**(3):339-346

2009;**11**(3):227

[13] Abramson S, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Research & Therapy.

[10] The National Institute for Health and Care Excellence. Osteoarthritis: Care and Management. 2014. Available

[11] Bahadır C, Onal B, Dayan V, Gürer N. Comparison of therapeutic effects of sodium hyaluronate and corticosteroid injections on trapeziometacarpal joint osteoarthritis. Clinical Rheumatology.

[12] Leung G, Rainsford K, Kean W. Osteoarthritis of the hand I: Aetiology

[14] Dahaghin S, Bierma-zeinstra S, Hazes J, Koes B. Clinical burden of radiographic hand osteoarthritis: A systematic appraisal. Arthritis and Rheumatism. 2006;**55**(4):636-647

[15] Kloppenburg M, Stamm T, Watt I, Kainberger F, Cawston T, Birrell F, et al. Research in hand osteoarthritis: Time for reappraisal and demand

and pathogenesis, risk factors, investigation and diagnosis. Journal of Pharmacy and Pharmacology.

recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic

2012;**64**(4):465-474

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

[1] Hunter D, Felson D. Osteoarthritis.

[3] Zhang Y. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. American Journal of Epidemiology. 2002;**156**(11):1021-1027

[4] Dahaghin S, Bierma-Zeinstra S, Reijman M, Pols H, Koes B. Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study). Annals of the Rheumatic Diseases. 2005;**64**(1):99- 104. Available from: https://www.ncbi. nlm.nih.gov/pubmed/15608306

[5] Sofat N, Jeyabaladevan S. Hand osteoarthritis—Clinical presentation, phenotypes and management. In: chen Q , editors. Osteoarthritis—Progress in Basic Research and Treatment. InTech;

[6] Felson D. An update on the pathogenesis and epidemiology of osteoarthritis. Radiologic Clinics of North America. 2004;**42**(1):1-9

[7] Beasley J, Ward L, Knipper-Fisher K, Hughes K, Lunsford D, Leiras C. Conservative therapeutic interventions for osteoarthritic finger joints: A systematic review. Journal of Hand Therapy. 2018. DOI: 10.1016/j.

[8] Hochberg M, Altman R, April K, Benkhalti M, Guyatt G, McGowan J, et al. American College of

Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and

2015. pp. 87-98

jht.2018.01.001

[2] Lawrence R, Felson D, Helmick C, Arnold L, Choi H, Deyo R, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis and Rheumatism. 2007;**58**(1):26-35

BMJ. 2006;**332**(7542):639-642

**References**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*

#### **References**

*Osteoarthritis Biomarkers and Treatments*

changes in HOA that are associated with significant symptomatic burden of pain and functional impairment. MRI and US have been shown to be effective imaging modalities that detect more structural changes that plain radiography alone. MRI allows examination of the joint as a whole organ to directly visualise intra-articular structures significant to the progression of OA such as BMLs, synovitis, osteophytes and erosions in relation to radiographic changes and pain. Our systematic review has also found that synovitis and BMLs in HOA which are detectable by MRI and US in particular, are associated with progression in symptoms over time and therefore may represent valid targets for future interventions aimed at modifying these structural changes. Joint space narrowing and osteophyte formation were also identified to have good correlation between plain radiography and MRI/US identified changes. Future novel therapeutics would benefit from correlation with changes in synovitis, BMLs and joint space narrowing in relation to pain and functional outcome for HOA. Our systematic review has found that a number of different cohorts around the world demonstrate structural changes observed in HOA. However, the majority of the studies were in European populations. Future studies in distinct Ethnic groups around the world would be helpful to compare and contrast data from existing

Since HOA has a higher prevalence in females, as reflected by the preponderance

Emerging data from the articles we have reviewed suggest that people with HOA could potentially be stratified for imaging-based structural changes e.g. subjects showing inflammatory changes as evidenced by US or MRI-defined synovitis that could be targeted by NSAIDs or intra-articular steroid injections, or a predominant bone-cartilage damage profile, evidenced by the presence of MRI-defined cartilage loss, joint space narrowing and bone oedema that could be targeted using novel therapeutic agents. Imaging modalities such as MRI and/or US that demonstrate additional structural changes not visualised by plain radiography could aid in improved

of women participants in the studies we identified, future studies which report changes in male participants with HOA, with data on occupation, since manual occupations are known to have a higher risk of HOA, are to be welcomed to compare

**98**

**Author details**

published studies.

London, UK

provided the original work is properly cited.

\*Address all correspondence to: nsofat@sgul.ac.uk

Nidhi Sofat\* and Soraya Koushesh

and contrast the changes observed.

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

Institute for Infection and Immunity, St George's, University of London,

stratification and development of novel therapeutics for HOA in the future.

[1] Hunter D, Felson D. Osteoarthritis. BMJ. 2006;**332**(7542):639-642

[2] Lawrence R, Felson D, Helmick C, Arnold L, Choi H, Deyo R, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis and Rheumatism. 2007;**58**(1):26-35

[3] Zhang Y. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. American Journal of Epidemiology. 2002;**156**(11):1021-1027

[4] Dahaghin S, Bierma-Zeinstra S, Reijman M, Pols H, Koes B. Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study). Annals of the Rheumatic Diseases. 2005;**64**(1):99- 104. Available from: https://www.ncbi. nlm.nih.gov/pubmed/15608306

[5] Sofat N, Jeyabaladevan S. Hand osteoarthritis—Clinical presentation, phenotypes and management. In: chen Q , editors. Osteoarthritis—Progress in Basic Research and Treatment. InTech; 2015. pp. 87-98

[6] Felson D. An update on the pathogenesis and epidemiology of osteoarthritis. Radiologic Clinics of North America. 2004;**42**(1):1-9

[7] Beasley J, Ward L, Knipper-Fisher K, Hughes K, Lunsford D, Leiras C. Conservative therapeutic interventions for osteoarthritic finger joints: A systematic review. Journal of Hand Therapy. 2018. DOI: 10.1016/j. jht.2018.01.001

[8] Hochberg M, Altman R, April K, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and

knee. Arthritis Care & Research. 2012;**64**(4):465-474

[9] Zhang W, Doherty M, Leeb B, Alekseeva L, Arden N, Bijlsma J, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2007;**66**(3):377-388

[10] The National Institute for Health and Care Excellence. Osteoarthritis: Care and Management. 2014. Available from: https://www.nice.org.uk/ guidance/cg177/resourcese [Accessed: 18 May 2017]

[11] Bahadır C, Onal B, Dayan V, Gürer N. Comparison of therapeutic effects of sodium hyaluronate and corticosteroid injections on trapeziometacarpal joint osteoarthritis. Clinical Rheumatology. 2009;**28**(5):529-533

[12] Leung G, Rainsford K, Kean W. Osteoarthritis of the hand I: Aetiology and pathogenesis, risk factors, investigation and diagnosis. Journal of Pharmacy and Pharmacology. 2013;**66**(3):339-346

[13] Abramson S, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Research & Therapy. 2009;**11**(3):227

[14] Dahaghin S, Bierma-zeinstra S, Hazes J, Koes B. Clinical burden of radiographic hand osteoarthritis: A systematic appraisal. Arthritis and Rheumatism. 2006;**55**(4):636-647

[15] Kloppenburg M, Stamm T, Watt I, Kainberger F, Cawston T, Birrell F, et al. Research in hand osteoarthritis: Time for reappraisal and demand

for new strategies. An opinion paper. Annals of the Rheumatic Diseases. 2007;**66**(9):1157-1161

[16] Yusuf E, Kortekaas M, Watt I, Huizinga T, Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Annals of the Rheumatic Diseases. 2010;**70**(1):60-67

[17] Deveza L, Melo L, Yamato T, Mills K, Ravi V, Hunter D. Knee osteoarthritis phenotypes and their relevance for outcomes: A systematic review. Osteoarthritis and Cartilage. 2017;**25**(12):1926-1941

[18] Haugen I, Bøyesen P, Slatkowsky-Christensen B, Sesseng S, van der Heijde D, Kvien T. Associations between MRIdefined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis. Annals of the Rheumatic Diseases. 2011;**71**(6):899-904

[19] Haugen I, Slatkowsky Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien T. Increasing synovitis and bone marrow lesions are associated with incident joint tenderness in hand osteoarthritis. Annals of the Rheumatic Diseases. 2015;**75**(4):702-708

[20] Haugen I, Lillegraven S, Slatkowsky-Christensen B, Haavardsholm E, Sesseng S, Kvien T, et al. Hand osteoarthritis and MRI: Development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score. Annals of the Rheumatic Diseases. 2011;**70**(6):1033-1038

[21] Haugen I, Bøyesen P, Slatkowsky-Christensen B, Sesseng S, Bijsterbosch J, van der Heijde D, et al. Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis. Annals of the Rheumatic Diseases. 2011;**71**(3):345-350

[22] Haugen I, Eeg I, Slatkowsky-Christensen B, Sesseng S, Kvien T. Predictive value of MRI-defined synovitis, bone marrow lesions and central erosions on pain and physical function in hand osteoarthritis. Osteoarthritis and Cartilage. 2014;**22**:S386-S387

[23] Haugen I, Slatkowsky-Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien T. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Annals of the Rheumatic Diseases. 2014;**75**(1):117-123

[24] Kortekaas M, Kwok W, Reijnierse M, Wolterbeek R, Boyesen P, van der Heijde D, et al. Magnetic resonance imaging in hand osteoarthritis: Intraobserver reliability and criterion validity for clinical and structural characteristics. The Journal of Rheumatology. 2015;**42**(7):1224-1230

[25] Haugen I, Eshed I, Gandjbakhch F, Foltz V, Ostergaard M, Boyesen P, et al. The longitudinal reliability and responsiveness of the OMERACT hand osteoarthritis magnetic resonance imaging scoring system (HOAMRIS). The Journal of Rheumatology. 2015;**42**(12):2486-2491

[26] Ramonda R, Favero M, Vio S, Lacognata C, Frallonardo P, Belluzzi E, et al. A recently developed MRI scoring system for hand osteoarthritis: Its application in a clinical setting. Clinical Rheumatology. 2016;**35**(8):2079-2086

[27] Damman W, Liu R, Bloem J, Rosendaal F, Reijnierse M, Kloppenburg M. Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis. Annals of the Rheumatic Diseases. 2016;**76**(1):214-217

[28] Roux C, Foltz V, Maheu E, Baron G, Gandjbakhch F, Lukas C, et al. MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritis. Clinical

**101**

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural…*

*DOI: http://dx.doi.org/10.5772/intechopen.81786*

and Experimental Rheumatology.

[29] Liu R, Damman W, Reijnierse M, Bloem J, Rosendaal F, Kloppenburg M. Bone marrow lesions on magnetic resonance imaging in hand osteoarthritis are associated with pain and interact with synovitis. Osteoarthritis and Cartilage.

[30] Kroon F, van Beest S, Ermurat S, Kortekaas M, Bloem J, Reijnierse M, et al. In thumb base osteoarthritis structural damage is more strongly associated with pain than synovitis. Osteoarthritis and Cartilage. 2018;**26**(9):1196-1202

[31] Kroon F, van der Plas J, van Beest S, Damman W, Kloppenburg M. Investigation of self-reported painful joint count as an outcome measure in hand osteoarthritis. Osteoarthritis and

Cartilage. 2018;**26**:S213-S214

[32] Wolski M, Podsiadlo P, Stachowiak G, Englund M, Haugen I. Trabecular bone texture detected by plain radiography is associated with MRIdefined osteophytes in finger joints of women without radiographic osteoarthritis. Osteoarthritis and Cartilage. 2018;**26**(7):924-928

[33] Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: A randomised, multicentre, doubleblind, placebo-controlled trial. Annals of the Rheumatic Diseases.

[34] Loef M, Kroon F, Bergstra S, van der Pol J, Lems W, Kerstens P, et al. TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years. Rheumatology.

2014;**74**(9):1697-1705

2018;**57**(11):1917-1924

2016;**34**(6):991-998

2017;**25**(7):1093-1099

*Evaluating the Relation between Bone Marrow Lesions and Synovitis with Pain and Structural… DOI: http://dx.doi.org/10.5772/intechopen.81786*

and Experimental Rheumatology. 2016;**34**(6):991-998

*Osteoarthritis Biomarkers and Treatments*

for new strategies. An opinion paper. Annals of the Rheumatic Diseases.

Predictive value of MRI-defined synovitis, bone marrow lesions and central erosions on pain and physical function in hand osteoarthritis. Osteoarthritis and Cartilage.

[23] Haugen I, Slatkowsky-Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien T. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Annals of the Rheumatic

[24] Kortekaas M, Kwok W, Reijnierse M, Wolterbeek R, Boyesen P, van der Heijde D, et al. Magnetic resonance imaging in hand osteoarthritis: Intraobserver reliability and criterion validity for clinical and structural characteristics.

Diseases. 2014;**75**(1):117-123

The Journal of Rheumatology.

[25] Haugen I, Eshed I, Gandjbakhch F, Foltz V, Ostergaard M, Boyesen P, et al. The longitudinal reliability and responsiveness of the OMERACT hand osteoarthritis magnetic resonance imaging scoring system (HOAMRIS). The Journal of Rheumatology.

2015;**42**(7):1224-1230

2015;**42**(12):2486-2491

[26] Ramonda R, Favero M, Vio S, Lacognata C, Frallonardo P, Belluzzi E, et al. A recently developed MRI scoring system for hand osteoarthritis: Its application in a clinical setting. Clinical Rheumatology. 2016;**35**(8):2079-2086

[27] Damman W, Liu R, Bloem J,

Diseases. 2016;**76**(1):214-217

[28] Roux C, Foltz V, Maheu E, Baron G, Gandjbakhch F, Lukas C, et al. MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritis. Clinical

Rosendaal F, Reijnierse M, Kloppenburg M. Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis. Annals of the Rheumatic

2014;**22**:S386-S387

[16] Yusuf E, Kortekaas M, Watt I, Huizinga T, Kloppenburg M. Do knee abnormalities visualised on MRI explain

knee pain in knee osteoarthritis? A systematic review. Annals of the Rheumatic Diseases. 2010;**70**(1):60-67

[17] Deveza L, Melo L, Yamato T, Mills K, Ravi V, Hunter D. Knee osteoarthritis phenotypes and their relevance for outcomes: A systematic review. Osteoarthritis and Cartilage.

[18] Haugen I, Bøyesen P, Slatkowsky-Christensen B, Sesseng S, van der Heijde D, Kvien T. Associations between MRIdefined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis. Annals of the Rheumatic

[19] Haugen I, Slatkowsky Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien T. Increasing synovitis and bone marrow lesions are associated with incident joint tenderness in hand osteoarthritis. Annals of the Rheumatic

[20] Haugen I, Lillegraven S, Slatkowsky-

[21] Haugen I, Bøyesen P, Slatkowsky-Christensen B, Sesseng S, Bijsterbosch J, van der Heijde D, et al. Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis. Annals of the Rheumatic Diseases. 2011;**71**(3):345-350

[22] Haugen I, Eeg I, Slatkowsky-Christensen B, Sesseng S, Kvien T.

Diseases. 2011;**71**(6):899-904

Diseases. 2015;**75**(4):702-708

2011;**70**(6):1033-1038

Christensen B, Haavardsholm E, Sesseng S, Kvien T, et al. Hand osteoarthritis and MRI: Development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score. Annals of the Rheumatic Diseases.

2017;**25**(12):1926-1941

2007;**66**(9):1157-1161

**100**

[29] Liu R, Damman W, Reijnierse M, Bloem J, Rosendaal F, Kloppenburg M. Bone marrow lesions on magnetic resonance imaging in hand osteoarthritis are associated with pain and interact with synovitis. Osteoarthritis and Cartilage. 2017;**25**(7):1093-1099

[30] Kroon F, van Beest S, Ermurat S, Kortekaas M, Bloem J, Reijnierse M, et al. In thumb base osteoarthritis structural damage is more strongly associated with pain than synovitis. Osteoarthritis and Cartilage. 2018;**26**(9):1196-1202

[31] Kroon F, van der Plas J, van Beest S, Damman W, Kloppenburg M. Investigation of self-reported painful joint count as an outcome measure in hand osteoarthritis. Osteoarthritis and Cartilage. 2018;**26**:S213-S214

[32] Wolski M, Podsiadlo P, Stachowiak G, Englund M, Haugen I. Trabecular bone texture detected by plain radiography is associated with MRIdefined osteophytes in finger joints of women without radiographic osteoarthritis. Osteoarthritis and Cartilage. 2018;**26**(7):924-928

[33] Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: A randomised, multicentre, doubleblind, placebo-controlled trial. Annals of the Rheumatic Diseases. 2014;**74**(9):1697-1705

[34] Loef M, Kroon F, Bergstra S, van der Pol J, Lems W, Kerstens P, et al. TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years. Rheumatology. 2018;**57**(11):1917-1924

### *Edited by Hechmi Toumi and Marija Mazor*

This book presents exclusive and comprehensive insight into the detailed molecular mechanisms of osteoarthritis (OA) initiation, progression and current advancements in the field. Inputs from clinician scientists, research and expertise offer a complete explanation of the current understanding of the pathogenesis of OA and practice in imaging and treatments strategies. Contributions from leading scientists provide a detailed introduction in the use of biomarkers in clinical research as well as in clinical practice and OA diagnosis. This book further discusses the potential of regenerative therapies and recent advances in cardiovascular and functional capacity on patients with OA.

Published in London, UK © 2019 IntechOpen © lnzyx / iStock

Osteoarthritis Biomarkers and Treatments

IntechOpen Book Series

Rheumatology, Volume 2

Osteoarthritis Biomarkers

and Treatments

*Edited by Hechmi Toumi and Marija Mazor*